People · Operator

Scott Grizzle

Named in public records as an officer, director or promoter · active 2009–2016 · Other Technology, Pharma

2
Companies
3
Filings
$2.0M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NEXPLORE CorpOther TechnologySeed$1.1M$35.8M2009
UVLrx Therapeutics, Inc.PharmaPre-Seed$980K$9.7M2014
Operator network

Scott Grizzle at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Edward Mandel · 2 companies · 1 sharedEdward MandelEarl Calhoun · 1 companies · 1 sharedEarl CalhounEddy Layne · 1 companies · 1 sharedEddy LayneSteven Gummer · 1 companies · 1 sharedSteven GummerRowland Hanson · 4 companies · 1 sharedRowland HansonR. Scott Grizzle · 2 companies · 1 sharedR. Scott GrizzleMichael Harter · 1 companies · 1 sharedMichael HarterMitchell Wortzman · 1 companies · 1 sharedMitchell WortzmanRyan Scott Maloney · 1 companies · 1 sharedRyan Scott MaloneyTom DiGiovanni · 1 companies · 1 sharedTom DiGiovanniVICTOR SCHEEREN · 1 companies · 1 sharedVICTOR SCHEERENVictor Scott Scheeren · 1 companies · 1 sharedVictor Scott Sche…Victor Sheeren · 1 companies · 1 sharedVictor SheerenNEXPLORE Corp · $1.1M raisedNEXPLORE CorpUVLrx Therapeutics, Inc. · $1.0M raisedUVLrx Therapeutics, I…Scott GrizzleSG
Scott Grizzle Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Scott Grizzle on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Rowland Hanson14
R. Scott Grizzle12
Edward Mandel12
Tom DiGiovanni11
Victor Scott Scheeren11
Ryan Scott Maloney11
VICTOR SCHEEREN11
Steven Gummer11
Earl Calhoun11
Victor Sheeren11
Eddy Layne11
Michael Harter11
Mitchell Wortzman11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.